Wall Street Newcomer Blitzed With Analyst Bull Notes

The stock is still trading well atop its IPO price of $39 per share

by Lillian Currens

Published on Oct 7, 2019 at 10:10 AM

Wall Street newbie 10X Genomics Inc (NASDAQ:TXG) is in focus after not one, but two analysts initiated coverage on the biotech this morning. Specifically, Cowen started following TXG with a "buy" rating, and a $55 price target, while J.P. Morgan Securities began coverage with an "overweight" rating, also giving the equity a $55 price target.

Cowen cited the firm's "early success, tremendous promise, favorable business model and competitive positioning" for the bull note. Meanwhile, J.P. Morgan Securities said the company's attractive revenue growth profile exceeded that of its sector peers. 

These analysts joined Evercore ISI, which initiated coverage on TXG with an "outperform" rating on Sept. 24. The consensus 12-month target price is now docked at $62.50 -- a solid 21.5% premium to last night's close, and right below the stock's Sept. 19 all-time high of $63.38. 

On the charts, it looks like the $45 level has emerged as a floor for the equity -- with the shares bouncing off this level last week. This is still well above TXG's initial public offering (IPO) price of $39 per share. However, the $52.75 region has contained the security in recent sessions, and is where the stock closed at on Sept. 12, its first day of trading on the Nasdaq. Earlier today, the equity rallied all the way up to $52.80, but was last seen down 2.7% at $50.04.


A Schaeffer's exclusive


Access your FREE insider report before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

Former Hedge Fund Manager Makes $25,000 "Trading Breakthrough"
Click to continue to advertiser's site.
Dow Cools as Coronavirus Outbreak Takes Grasp of Markets
The Nasdaq is about to snap a six-week win streak
Copper Stock Picks Up Bear Notes After Earnings
FCX gapped lower yesterday after earnings
Former Hedge Fund Manager Makes $25,000 "Trading Breakthrough"
Click to continue to advertiser's site.